Ari Kellen, MD


Ari Kellen, MD, is a seasoned senior executive with over three decades of health care industry experience, both in management consulting and in major global P&L and operational roles. 


After being recruited by McKinsey & Company, he spent 23 years serving health care clients around the world. Dr. Kellen served for more than a decade as a senior McKinsey partner, advising CEOs and Board members at large industry-leading healthcare companies and small rapidly growing entities. His experience spans biotechnology, medical device, payor and provider organizations, and includes work focused on mergers and acquisitions, business development, new company spin-outs, corporate and business unit level turnarounds, R&D portfolio strategy, and product/therapeutic area growth strategies. Dr. Kellen also played significant roles in McKinsey helping to build the Firm over 20 years including senior client leadership roles in Health Care, leading the Global Innovation Practice, and co-chairing the Firm’s Partner Review Committee.

In 2014 Dr. Kellen was recruited to Bausch + Lomb/Valeant where he ran a multibillion dollar P&L for three years across the US and Latin America. As EVP and General Manager of US Bausch + Lomb, he successfully launched and commercialized new products in Pharmaceuticals, Surgical, and Vision Care/Contact Lenses. He led global portfolio assessment for B+L including internal R&D development and external business acquisition. At varying points during his tenure at the company he was responsible for brand and portfolio management across several additional therapeutic areas including Dermatology and GI.  Dr. Kellen was also responsible for leading the US R&D organization to advance more than 100 active R&D projects across Dermatology, Ophthalmology, Oncology, Gastroenterology and Consumer products.

Dr. Kellen has a Medical Degree and MBA from Witwatersrand University, South Africa (both with distinction).